Page last updated: 2024-11-03

propranolol and Precursor Cell Lymphoblastic Leukemia-Lymphoma

propranolol has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 1 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Precursor Cell Lymphoblastic Leukemia-Lymphoma: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lamkin, DM1
Sloan, EK1
Patel, AJ1
Chiang, BS1
Pimentel, MA1
Ma, JC1
Arevalo, JM1
Morizono, K1
Cole, SW1

Other Studies

1 other study available for propranolol and Precursor Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
Chronic stress enhances progression of acute lymphoblastic leukemia via β-adrenergic signaling.
    Brain, behavior, and immunity, 2012, Volume: 26, Issue:4

    Topics: Adrenergic beta-Antagonists; Animals; Cell Line, Tumor; Cyclic AMP; Disease Models, Animal; Disease

2012